BioCentury
ARTICLE | Product Development

COVID-19 update: U.S. test capacity to reach 10,000/day; pharma White House meeting Monday; Scangos heading BIO response

March 1, 2020 5:18 AM UTC
Updated on Mar 25, 2020 at 12:34 AM UTC

The first death in the U.S. attributed to COVID-19 was disclosed on Feb. 29. Within hours the federal government and the biopharmaceutical industry announced new responses to the outbreak.

FDA released a policy that will quickly expand COVID-19 testing, President Donald Trump told reporters about a White House meeting with pharmaceutical industry leaders, and BIO made public an initiative to bring the biotech industry into the fight. ...